Anna Marsal-Beltran

Anna Marsal-Beltran

Auto-generated profile, based on publicly available information

Anna Marsal-Beltran

Institut de Recerca Biomèdica Catalunya Sud (formerly Institut d’Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona 43005, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2024 in Diabetologia
Verified
Journal Article
Open access
PDF file
SFSonia Fernández-Veledo
Sonia Fernández-Veledo
AMAnna Marsal-Beltran
Anna Marsal-Beltran
Vendrell JoanVendrell Joan
Vendrell Joan
Beyond their conventional roles in intracellular energy production, some traditional metabolites also function as extracellular messengers that activate cell-surface G-protein-coupled receptors (GPCRs) akin to hormones and neurotransmitters. These signalling metabolites, often derived from nutrients, the gut microbiota or the host’s intermediary metabolism, are now acknowledged as key regulators of various metabolic and immune responses. This review delves into the multi-dimensional aspects of succinate, a dual metabolite with roots in both the mitochondria and microbiome. It also connects the dots between succinate’s role in the Krebs cycle, mitochondrial respiration, and its double-edge function as a signalling transmitter within and outside the cell. We aim to provide an overview of the role of the succinate–succinate receptor 1 (SUCNR1) axis in diabetes, discussing the potential use of succinate as a biomarker and the novel prospect of targeting SUCNR1 to manage complications associated with diabetes. We further propose strategies to manipulate the succinate–SUCNR1 axis for better diabetes management; this includes pharmacological modulation of SUCNR1 and innovative approaches to manage succinate concentrations, such as succinate administration and indirect strategies, like microbiota modulation. The dual nature of succinate, both in terms of origins and roles, offers a rich landscape for understanding the intricate connections within metabolic diseases, like diabetes, and indicates promising pathways for developing new therapeutic strategies. Graphical Abstract

23 June 2025 in EBioMedicine
Verified
Journal Article
Open access
VCVictòria Ceperuelo-Mallafré
Victòria Ceperuelo-Mallafré
MRM-Mar Rodríguez-Peña
M-Mar Rodríguez-Peña
JBJoan Badia
Joan Badia
TVTeresa Villanueva-Carmona
Teresa Villanueva-Carmona
LCLídia Cedó
Lídia Cedó
JVJoan Vendrell
Joan Vendrell
Intermittent fasting holds promise as a prevention for obesity, but its effects on established obesity remain uncertain. We examined two intermittent fasting regimens in diet-induced obese mice, either maintained on a hypercaloric diet or switched to normal chow diet, and compared their effects with those of dietary switch alone (12 mice/group). We assessed metabolic parameters, gut microbiota composition, and fasting and postprandial short-chain fatty acids (SCFAs) levels. Additionally, faecal microbiota was analysed before and after diet-induced weight loss in 18 individuals with obesity. Intermittent fasting with a hypercaloric diet effectively mitigated weight gain and improved metabolic health-glucose, insulin, total cholesterol, triglycerides, and glucose tolerance (p < 0.05) to an extent comparable with dietary switch. Intermittent fasting increased faecal SCFAs levels, especially postprandially (acetate, propionate, and butyrate, p < 0.05), mirroring dietary switch. Combining intermittent fasting with dietary switch yielded the greatest improvement in glucose tolerance (p < 0.01) and exerted a more pronounced effect on gut microbiota composition (28 significant genera), albeit with reduced SCFA changes. The relative abundance of Alistipes finegoldii was associated with postprandial SCFAs levels and/or metabolic parameters in both mice and humans. Intermittent fasting on a hypercaloric diet protects against obesity, while combining intermittent fasting with dietary switch improves glucose metabolism independently of body weight. Both effects are associated with specific microbiota changes and postprandial SCFA dynamics, highlighting the connection between intermittent fasting, microbiota, and metabolic health. Supported by the Institute of Health "Carlos III", Ministry of Science and Innovation and "La Caixa" Foundation.

12 June 2026 in Science Advances
Verified
Journal Article
Open access
AMAnna Marsal-Beltran
Anna Marsal-Beltran
LSLaura Salmerón-Pelado
Laura Salmerón-Pelado
ARAleix Ribas-Latre
Aleix Ribas-Latre
MRMaria Repollés-De-Dalmau
Maria Repollés-De-Dalmau
MRM-Mar Rodríguez-Peña
M-Mar Rodríguez-Peña
SFSonia Fernández-Veledo
Sonia Fernández-Veledo
Succinate, a mitochondrial metabolite, also functions as an extracellular signal through its receptor succinate receptor 1 (SUCNR1), coordinating responses to nutrient availability. The physiological role of SUCNR1 within hepatocytes, however, is unclear. We show that hepatic succinate levels and Sucnr1 expression are dynamically regulated by nutritional status. Mice lacking Sucnr1 in hepatocytes [Hep- Sucnr1 knockout (KO)] exhibit a fasting-like phenotype characterized by enhanced gluconeogenesis, elevated amino acids, and impaired metabolic flexibility. Mechanistically, loss of Sucnr1 compromises glucose-derived oxidative flux through the tricarboxylic acid cycle, increases reliance on glutamine-dependent anaplerosis, and induces mitochondrial stress adaptations. Upon refeeding, Hep- Sucnr1 KO mice show blunted mammalian target of rapamycin activation, incomplete glycogen restoration, and an altered hepatic proteomic response. Sucnr1 expression increases during liver maturation, is enriched in pericentral hepatocytes, and its loss is associated with functional reprogramming of pericentral metabolic functions without disruption of zonation. Together, our findings establish SUCNR1 as a critical regulator of hepatic metabolic adaptation, linking succinate signaling to mitochondrial flexibility and nutrient-dependent metabolic responses.